About this report, this report is the 14th social responsibility catalogue issued by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) government
Any practice report. The report discloses the company’s economic, social, environmental and other aspects in 2021
Social responsibility concept, practice and related performance. We look forward to the release of social responsibility
Report, strengthen communication with stakeholders, build consensus and promote sustainable development.
Time frame 04 chairman’s speech
From January 1, 2021 to December 31, 2021, some contents are moderately extended to the previous and subsequent years. 06 ESG management
Report scope main data scope: 09 corporate governance
Unless otherwise specified, “Guangzhou Baiyun management takes” Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) “as the main body,
“Shan Pharmaceutical Group Co., Ltd.” includes its subsidiaries and joint ventures. 12 about Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332)
Entities, including their subordinates and joint ventures. Financial data extracted from Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332)
Annual report for 2021. 14 responsibility topic 1: at the beginning of the 18th year, the heart remains unchanged, love recycling, and protect health and the environment
Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) regularly reviews social responsibility, and employees take ” Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) ” as the main body,
The scope of the report to ensure that it covers the whole company, including all personnel employed by its subordinates and joint ventures. 16 responsibility topic 2: Party building leads to build a new engine for the development of the company
The biggest impact on the corporate business portfolio. Environment (emissions, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) and subsidiaries.
Energy consumption)
Preparation basis 18 sharing the right to health 30 building a transparent business
Gri standards 20 make health care better 32 foster business ethics
Cass-csr4.0 guidelines for the preparation of China’s corporate social responsibility report (cass-csr4.0) 24 make health more accessible 34 strengthen operational transparency
HKEx guidelines on environmental, social and governance reporting 36 building a responsible supply chain
Guidelines on environmental information disclosure of Listed Companies in Shanghai Stock Exchange issued by Shanghai Stock Exchange and guidance on better performance of social responsibility by state owned enterprises issued by SASAC of the State Council
Data source 38 co drawing green water and green mountains 48 co building the cornerstone of development
The data used in the report are from the company’s official documents, statistical reports or relevant public materials. 40 improve environmental management 50 employee rights and development
Reliability assurance 41 optimizing the use of resources 53 occupational health and safety
The company guarantees that there are no false records, misleading statements or major omissions in the contents of this report. 44 reduce environmental impact 55 product safety and quality
45 biodiversity conservation 57 public welfare and community development
Title Description 47 advocate the concept of environmental protection
For ease of expression and reading, in this report, “stakeholders” are sometimes represented by “you”, and ” Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) ” is sometimes represented by “Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) ” “company” or “we”.
The abbreviations used in the report are the same as those defined in the 2021 annual report
Same meaning. 59 outlook
Report get 60 ESG index
This report is provided in both paper and electronic forms. You can log in to the company’s website (www.gybys. Com. CN.) Website of Shanghai Stock Exchange (www.63 ESG key performance indicators SSE. Com. CN.) And HKEx website (www.hkex. Com. CN.) The report can be read online or downloaded electronically, or by email（ [email protected]. ）Or call (02066281011) to get the paper version of the report. This report is compiled in Chinese and English respectively. In case of any ambiguity in interpretation between the two versions, the Chinese version shall prevail.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) chairman’s speech
Chief Secretary
To 2021 is the 100th anniversary of the founding of the Communist Party of China and the beginning of the 14th five year plan. This year, Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) insisted on Xi Jinping new Guangzhou epidemic, and we urgently developed “suikang drug purchase”
Speech
Guided by the thought of socialism with Chinese characteristics in the times, closely following the company’s “14th five year plan” development plan, adhering to the dual planning and small procedures of epidemic prevention and control and enterprise development, thousands of Party members and comrades actively participated
With the long-term goal of human health and well-being and the responsibility concept of “Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) , love all over the world” as the goal, we will fight the epidemic at the front line. At present, we are the first to face the flood
Actively provide Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) with innovation, wisdom and strength for the development of human health. Give a helping hand. We are enthusiastic about social welfare
ESG shares the right to health and provides high-quality, accessible and extensive medical and health services. We strive to improve the pharmaceutical R & D capability, keep the integrity and innovation, and continue to polish the public welfare brand of loving Guangyao,
Manage
Explain “Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) , love” with practical actions
At present, there are nearly 200 projects under research, and Guangzhou Pharmaceutical Research Institute has obtained GLP full qualification certification. For 18 consecutive years, we have carried out free of charge for expired drugs in families
Recycling, actively explore fashionable traditional Chinese medicine, provide people with a new healthy lifestyle, and actively create a world with unique industrial characteristics and distinctive culture, with the enterprise concept of “one heart fills the world”.
Flow biomedicine and health enterprises. At present, the century changing situation and the century epidemic situation are intertwined and overlapped
The public should build transparent business and fulfill the business ethics practice of honesty, transparency and compliance. We attach importance to the construction of a clean team, actively carry out anti-corruption and anti bribery, and face the new development of opportunities and challenges
department
In the treatment stage, Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) will continue to play its role in life
Bribery training, attach great importance to the construction of integrity and compliance team, strictly implement the reporting system and whistleblower protection plan, and provide anti-corruption training for employees in 2021
Total training hours
